院外心脏骤停中被动抬腿的临床结局与安全性:一项随机对照试验
该随机对照试验在Camp de Tarragona地区纳入588例成人院外心脏骤停患者,随机分为被动抬腿组(301例)与平卧位对照组(287例),结局评估采用盲法。主要终点为出院时神经功能良好存活(CPC 1-2):被动抬腿组3.3% vs 对照组3.5%(OR 0.9;95%CI 0.4-2.3,p=0.91),无显著差异。入院存活率(OR 1.0;95%CI 0.7-1.6,p=0.95)及初始可除颤心律患者的入院存活率(OR 1.7;95%CI 0.8-3.4,p=0.15)亦无显著差异。肺部并发症、脑水肿、肺重量与脑重量等安全性指标均无显著差异。
要点
- 院外心脏骤停复苏时被动抬腿未改善出院时CPC 1-2存活:被动抬腿组3.3% vs 对照组3.5%(OR 0.9;95%CI 0.4-2.3,p=0.91)。
- 入院存活率全患者无显著差异:OR 1.0(95%CI 0.7-1.6,p=0.95);初始可除颤心律者OR 1.7(95%CI 0.8-3.4,p=0.15)。
- 胸部X线肺部并发症无差异:被动抬腿组7例(25.9%)vs 对照组5例(17.9%),p=0.47。
- 幸存者CT脑水肿无差异:被动抬腿组5例(29.4%)vs 对照组10例(32.6%),p=0.84。
- 106例尸检中肺重量[1223 mg(IQR 909-1500)vs 1239 mg(IQR 900-1507),p=0.82]与脑重量[1352 mg(IQR 1227-1457)vs 1380 mg(IQR 1255-1470),p=0.43]无差异。
适用人群与场景
- Camp de Tarragona地区院外心脏骤停的成人患者。
处置流程与药物剂量
- 被动抬腿组在复苏时采用被动抬腿,对照组采用平卧位。
研究设计与关键结果
- 随机对照试验,结局评估采用盲法,共纳入588例,被动抬腿组301例、对照组287例;男性67.8%,中位年龄72岁(IQR 60-82)。
- 主要终点出院时CPC 1-2存活:被动抬腿组3.3% vs 对照组3.5%(OR 0.9;95%CI 0.4-2.3,p=0.91)。
- 入院存活率全患者:OR 1.0(95%CI 0.7-1.6,p=0.95);初始可除颤心律患者:OR 1.7(95%CI 0.8-3.4,p=0.15)。
- 胸部X线肺部并发症:被动抬腿组7例(25.9%)vs 对照组5例(17.9%),p=0.47。
- 幸存者CT脑水肿:被动抬腿组5例(29.4%)vs 对照组10例(32.6%),p=0.84。
- 106例尸检肺重量:被动抬腿组1223 mg(IQR 909-1500)vs 对照组1239 mg(IQR 900-1507),p=0.82;脑重量:被动抬腿组1352 mg(IQR 1227-1457)vs 对照组1380 mg(IQR 1255-1470),p=0.43。
证据类型、等级与局限
- 证据类型:随机对照试验,结局评估采用盲法。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在本试验中院外心脏骤停心肺复苏时采用被动抬腿未改善出院时CPC 1-2存活,也未发现不良效应证据。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There are data suggesting that passive leg raising (PLR) improves hemodynamics during cardiopulmonary resuscitation (CPR). This trial aimed to determine the effectiveness and safety of PLR during CPR in out-of-hospital cardiac arrest (OHCA).
METHODS: We conducted a randomized controlled trial with blinded assessment of the outcomes that assigned adults OHCA to be treated with PLR or in the flat position. The trial was conducted in the Camp de Tarragona region. The main end point was survival to hospital discharge with good neurological outcome defined as cerebral performance category (CPC 1-2). To study possible adverse effects, we assessed the presence of pulmonary complications on the first chest X-rays, brain edema on the computerized tomography (CT) in survivors and brain and lungs weights from autopsies in non-survivors.
RESULTS: In total, 588 randomized cases were included, 301 were treated with PLR and 287 were controls. Overall, 67.8% were men and the median age was 72 (IQR 60-82) years. At hospital discharge, 3.3% in the PLR group and 3.5% in the control group were alive with CPC 1-2 (OR 0.9; 95% CI 0.4-2.3, p = 0.91). No significant differences in survival at hospital admission were found in all patients (OR 1.0; 95% CI 0.7-1.6, p = 0.95) and among patients with an initial shockable rhythm (OR 1.7; 95% CI 0.8-3.4, p = 0.15). There were no differences in pulmonary complication rates in chest X-rays [7 (25.9%) vs 5 (17.9%), p = 0.47] and brain edema on CT [5 (29.4%) vs 10 (32.6%), p = 0.84]. There were no differences in lung weight [1223 mg (IQR 909-1500) vs 1239 mg (IQR 900-1507), p = 0.82] or brain weight [1352 mg (IQR 1227-1457) vs 1380 mg (IQR 1255-1470), p = 0.43] among the 106 autopsies performed.
CONCLUSION: In this trial, PLR during CPR did not improve survival to hospital discharge with CPC 1-2. No evidence of adverse effects has been found. Clinical trial registration ClinicalTrials.gov: NCT01952197, registration date: September 27, 2013, https://clinicaltrials.gov/ct2/show/NCT01952197 .
参考来源
- Azeli Y, Bardají A, Barbería E, et al. Clinical outcomes and safety of passive leg raising in out-of-hospital cardiac arrest: a randomized controlled trial. Crit Care. 2021. PMID: 34034775. doi:10.1186/s13054-021-03593-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。